Massachusetts Medical Society: Module 12 - The Medical Use of Marijuana in Huntington’s Disease

Module 12 - The Medical Use of Marijuana in Huntington’s Disease

Module 12 - The Medical Use of Marijuana in Huntington’s Disease

Editors' Note: Medical marijuana has become an important area of study in healthcare. Doctors and healthcare professionals must understand the medical, legal, and social issues to best respond to their patients' questions and attend to their needs. This content area is not intended to encourage or dissuade the use of medical marijuana, but has been created to provide a balanced portrayal of the research in this area.

Created by Meredith Fisher-Corn, MD and Stephen B. Corn, MD

This online continuing education module will describe and discuss the existing clinical literature for cannabinoid-based medicines in Huntington's disease.

Learning Objectives

After reading this material, a participant will be able to:

  • Describe the existing clinical literature for cannabinoid-based medicines in Huntington's disease
  • Describe the widespread dysfunction in the ECS of patients with Huntington's disease
  • Describe the clinical trials that have evaluated cannabinoids for use in managing the signs and symptoms of Huntington's disease
  • List the important safety considerations when recommending cannabinoid-based medicines for patients with Huntington's disease and apply this knowledge to clinical practice
  • Discuss the American Academy of Neurology's opinion on the use of cannabinoid-based medicines for the treatment of Huntington's disease


Robert B Laprairie
Department of Pharmacology,
Dalhousie University, Halifax NS Canada

Amina M. Bagher, PhD Candidate
Department of Pharmacology, 
Dalhousie University, Halifax NS Canada

Eileen M. Denovan-Wright, PhD
Department of Pharmacology, 
Dalhousie University, Halifax NS Canada

Alan Ehrlich, MD
Clinical Assoc. Professor, University of Massachusetts School of Medicine (UMMS)

Meredith Fisher-Corn, MD

Stephen B. Corn, MD
Founding Editor-in-Chief,

Course Fees

Massachusetts Medical Society (MMS) Member: $12.00
Non-MMS Member: $22.00
Allied Health Professionals: $9.60



CME Credit

1.00 AMA PRA Category 1 Credit™  

Accreditation Statement for Joint Providership
This activity has been planned and implemented in accordance with the accreditation requirements and
policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint 
providership of the Massachusetts Medical Society and The Answer Page, Inc. The 
Massachusetts Medical Society is accredited by the ACCME to provide continuing medical education for 

AMA Credit Designation Statement 
The Massachusetts Medical Society designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the criteria for the Massachusetts Baord of Registration in Medicine for risk management study.

National Commission on Certification of Physician Assistants (NCCPA).

Physician Assistants may claim 1.00 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME or a recognized state medical society.

Continuing Education Credit for Pharmacists
The Board of Registration in Pharmacy in Massachusetts, (BOARD), accepts three continuing education types:  ACPE,  AMA PRA Category 1 Credit™ , and continuing education activities approved by any State Board of Pharmacy. 

Click here for a list of all state Boards of Pharmacy.

A score of 70% or higher is required to receive  AMA PRA Category 1 Credit(s)™.  

Activity Term

Original Release Date: June 15, 2017
Review Date: N/A
Termination Date: June 15, 2020

System requirements:

Windows, XP, Vista, 7, 8 
Mac OSX 10.6 higher 
Most modern browsers including: 
Firefox 18.0+ 
Chrome 26+ 
Safari 5+ 
Flash player is required for some Online CME courses.

iOS devices beginning with OS version 5 or higher (includes, iPhone, ipad and iTouch devices) 
Android devices including tablets and phones. 
Windows RT and tablets on Windows 8 are also supported.


Copyright © 2018. Massachusetts Medical Society, 860 Winter Street, Waltham Woods Corporate Center, Waltham, MA 02451-1411

(781) 893-4610 | (781) 893-3800 | Member Information Hotline: (800) 322-2303 x7311